Soluble guanylate cyclase is required during development for visual system function in Drosophila.
A requirement for nitric oxide (NO) in visual system development has been demonstrated in many model systems, but the role of potential downstream effector molecules has not been established. Developing Drosophila photoreceptors express an NO-sensitive soluble guanylate cyclase (sGC), whereas the optic lobe targets express NO synthase. Both of these molecules are expressed after photoreceptor outgrowth to the optic lobe, when retinal growth cones are actively selecting their postsynaptic partners. We have previously shown that inhibition of the NO-cGMP pathway in vitro leads to overgrowth of retinal axons. Here we examined flies mutant for the alpha subunit gene of the Drosophila sGC (Gcalpha1). This mutation severely reduced but did not abolish GCalpha1 protein levels and NO-stimulated sGC activity in the developing photoreceptors. Although few mutant individuals possessed a disorganized retinal projection pattern, pharmacological NOS inhibition during metamorphosis increased this disorganization in mutants to a greater degree than in the wild type. Adult mutants lacked phototactic behavior, and the off-transient component of electroretinograms was frequently absent or greatly reduced in amplitude. Normal phototaxis and off-transient amplitude were restored by heat shock-mediated Gcalpha1 expression applied during metamorphosis but not in the adult. We propose that diminished sGC activity in the visual system during development causes inappropriate or inadequate formation of first-order retinal synapses, leading to defects in visual system function and visually mediated behavior.
Gibbs
S M
SM
Graduate Program in Neurobiology and Behavior, Department of Zoology, University of Washington, Seattle, Washington 98195, USA. gibbs016@tc.umn.edu
Becker
A
A
Hardy
R W
RW
Truman
J W
JW
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects / Q000502:physiology; D004330:Drosophila; D004596:Electroretinography; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006162:Guanylate Cyclase / Q000235:genetics / Q000378:metabolism*; D007150:Immunohistochemistry; D066298:In Vitro Techniques; D008297:Male; D008675:Metamorphosis, Biological / Q000502:physiology; D009154:Mutation; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors / Q000378:metabolism; D009899:Optic Lobe, Nonmammalian / Q000166:cytology / Q000201:enzymology* / Q000254:growth & development; D010775:Photic Stimulation; D017956:Photoreceptor Cells, Invertebrate / Q000166:cytology / Q000201:enzymology* / Q000254:growth & development*; D021122:Protein Subunits; D012160:Retina / Q000166:cytology / Q000254:growth & development / Q000502:physiology; D014795:Visual Pathways / Q000166:cytology / Q000201:enzymology* / Q000254:growth & development
D004791:Enzyme Inhibitors; D021122:Protein Subunits; D019001:Nitric Oxide Synthase; D006162:Guanylate Cyclase